<Disease><Name>CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG)</Name><Synonym>CDG1A; PMM2-CDG; JAEKEN SYNDROME</Synonym><OMIM><Number>212065</Number><URL>http://omim.org/entry/212065</URL></OMIM><Orphanet><Number>79318</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79318</URL></Orphanet><Protein><Number>phosphomannomutase 2</Number><URL>http://www.uniprot.org/uniprot/O15305</URL></Protein><ExPASy><Number>5.4.2.8</Number><URL>http://enzyme.expasy.org/EC/5.4.2.8</URL></ExPASy><Gene>16p13.2</Gene><ICD>E77.8</ICD><Summary>rare (&gt;300 patients) ;autosomal recessive ;mutations in PMM2; two subtypes: a neurological form with psychomotor retardation, strabismus, cerebellar hypoplasia, and retinitis pigmentosa, and a multivisceral form with neurological and extraneurological manifestations including liver, cardiac, renal, or gastrointestinal involvement [de Lonlay P et al. 2001]</Summary><Symptoms><symtomp><id>2252</id><symptom>anorexia</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1738</id><symptom>ascites</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3782</id><symptom>behavior, anxiety</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2458</id><symptom>clinodactyly</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2133</id><symptom>Coagulopathy/Coagulation factors / Gerinnungsfaktoren [+]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2247</id><symptom>contractures, joints</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2367</id><symptom>demyelinisation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3313</id><symptom>enteropathy, protein-loosing</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3344</id><symptom>hyperinsulinism</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2214</id><symptom>hyporeflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2053</id><symptom>hypothyroidism</symptom><category>ENDOCRINE SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3455</id><symptom>intracranial hemorrhage, hematoma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3336</id><symptom>inverted nipples</symptom><category>BODY</category></symtomp><symtomp><id>2414</id><symptom>limb abnormalities, limb deformities / lower limb deformities</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2264</id><symptom>lipodystrophia</symptom><category>SKIN</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2106</id><symptom>nephromegaly / renal enlargement (large kidneys)</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2003</id><symptom>nephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3168</id><symptom>nephrotic syndrome / neprhrotic syndrome</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3962</id><symptom>osteopenia</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2482</id><symptom>pericardial effusion</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3629</id><symptom>proteinuria</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3996</id><symptom>renal enlargement</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp><symtomp><id>2263</id><symptom>strokelike episodes</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2116</id><symptom>trichorrhexis nodosa</symptom><category>SKIN</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1404</id><name>Coagulopathy/Coagulation factors</name><specimen /><value /><min>    </min><max>    </max><unit /><age /><method /><comment /></metabolite><metabolite><id>1183</id><name>Albumin</name><specimen>plasma</specimen><value /><min>25.00</min><max>34.00</max><unit>g/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>836</id><name>alpha1-Antitrypsine</name><specimen>serum</specimen><value>decreased</value><min>100.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1003</id><name>Antithrombin III (AT III)</name><specimen>blood</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>%</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1119</id><name>Asialotransferrin</name><specimen>serum</specimen><value>increased</value><min>    </min><max>1.00</max><unit>% of total transferrin</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1123</id><name>Carbohydrate-deficient transferrins</name><specimen>serum</specimen><value>increased</value><min>12.00</min><max>24.00</max><unit>mg/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1034</id><name>Coagulopathy/Coagulation factors</name><specimen>plasma</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1118</id><name>Disialotransferrin</name><specimen>serum</specimen><value>increased</value><min>    </min><max>8.00</max><unit>% of total transferrin</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>835</id><name>Haptoglobin</name><specimen>serum</specimen><value>decreased</value><min>250.00</min><max>1750.00</max><unit>mg/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1124</id><name>Phosphomannomutase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1120</id><name>Tetrasialotransferrin</name><specimen>serum</specimen><value>decreased</value><min>50.00</min><max>65.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>722</id><name>Thyroxine binding globuline (TBG)</name><specimen>serum</specimen><value>normal/dec</value><min>22.00</min><max>42.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>723</id><name>Transferrin</name><specimen>serum</specimen><value>normal/dec</value><min>130.00</min><max>430.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6438</id><title>Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms</title><author>Moreira-Silva H,</author><journal>Eur J Pediatr</journal><year>2019</year><book /><volume>178</volume><number>4</number><pages>515-523</pages><co_aut>et al.</co_aut></literature><literature><id>6625</id><title>Unusual Presentation of PMM2-Congenital Disorder of Glycosylation With Isolated Strokelike Episodes in a Young Girl</title><author>Farmania R,</author><journal>J Child Neurol</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6626</id><title>AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2-CDG</title><author>Mart&#237;nez-Monseny AF,</author><journal>Ann Neurol</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6683</id><title>Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glyc</title><author>Lefrere B,</author><journal>Thromb Res</journal><year>2019</year><book /><volume>178</volume><number>0</number><pages>75-78</pages><co_aut>et al.</co_aut></literature><literature><id>6687</id><title>International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, </title><author>Altassan R,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>1</number><pages>5-28</pages><co_aut>et al.</co_aut></literature><literature><id>6925</id><title>Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain</title><author>Medrano C,</author><journal>Clin Genet</journal><year>2019</year><book /><volume>95</volume><number>5</number><pages>615-626</pages><co_aut>et al.</co_aut></literature><literature><id>6943</id><title>Non-Immune Hydrops Fetalis and Congenital Disorders of Glycosylation: A Systematic Literature Review</title><author>Makhamreh MM,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7994</id><title>Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients</title><author>Moravej H,</author><journal>JIMD Rep</journal><year>2019</year><book /><volume>51</volume><number>1</number><pages>76-81</pages><co_aut>et al.</co_aut></literature><literature><id>6429</id><title>Yeast Models Of Phosphomannomutase 2 Deficiency, A Congenital Disorder Of Glycosylation</title><author>Lao JP,</author><journal>G3 (Bethesda)</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6926</id><title>Clinical Assessment of Dysarthria in Children with Cerebellar Syndrome Associated with PMM2-CDG</title><author>Itzep D,</author><journal>Neuropediatrics</journal><year>2018</year><book /><volume>49</volume><number>6</number><pages>408-413</pages><co_aut>et al.</co_aut></literature><literature><id>5152</id><title>Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2</title><author>Cabezas OR,</author><journal>J Am Soc Nephrol</journal><year>2017</year><book /><volume>28</volume><number>8</number><pages>2529-2539</pages><co_aut>et al.</co_aut></literature><literature><id>5213</id><title>Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature</title><author>Marques-da-Silva D,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3403</id><title>Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestatio</title><author>Choi R,</author><journal>Clin Chim Acta</journal><year>2015</year><book /><volume>444</volume><number>0</number><pages>50-53</pages><co_aut>et al.</co_aut></literature><literature><id>4288</id><title>Congenital Disorders of Glycosylation: A Review</title><author>Albahri Z</author><journal>American Journal of Pediatrics</journal><year>2015</year><book /><volume>1</volume><number>2</number><pages>6-28</pages><co_aut /></literature><literature><id>3404</id><title>29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype</title><author>Monin ML,</author><journal>Orphanet J Rare Dis</journal><year>2014</year><book /><volume>11</volume><number>9</number><pages>207</pages><co_aut>et al.</co_aut></literature><literature><id>3400</id><title>Congenital disorders of glycosylation</title><author>Jaeken J</author><journal>Handb Clin Neurol</journal><year>2013</year><book>Handb Clin Neurol</book><volume>0</volume><number>113</number><pages>1737-1743</pages><co_aut /></literature><literature><id>2983</id><title>Congenital disorder of glycosylation type Ia: Heterogeneity in the clinical presentation from multivisceral failure to hyperins</title><author>Shanti B</author><journal>J Inherit Metab Dis</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2984</id><title>Towards a therapy for phosphomannomutase 2 defeciency, the defect in CDG-Ia patients</title><author>Freeze HH</author><journal>Biochim Biophys Acta</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>2985</id><title>The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).</title><author>Grunewald S</author><journal>Biochim Biophys Acta</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>2986</id><title>Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations</title><author>Perez-Duenas B</author><journal>Eur J Paediatr Neurol</journal><year>2009</year><book /><volume>13</volume><number>5</number><pages>444-451</pages><co_aut>et al.</co_aut></literature><literature><id>2988</id><title>Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblast</title><author>Higashidani A</author><journal>Mol Genet Metab</journal><year>2009</year><book /><volume>96</volume><number>4</number><pages>268-272</pages><co_aut>et al.</co_aut></literature><literature><id>3000</id><title>Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital di</title><author>Quintana E</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2009</year><book /><volume>877</volume><number>24</number><pages>2513-2518</pages><co_aut>et al.</co_aut></literature><literature><id>2987</id><title>Congenital disorders of glycosylation type Ia as a cause of mirror syndrome</title><author>Wurm D</author><journal>J Perinatol</journal><year>2007</year><book /><volume>27</volume><number>12</number><pages>802-804</pages><co_aut>et al.</co_aut></literature><literature><id>2989</id><title>Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy</title><author>Hardre R</author><journal>Bioorg Med Chem Lett</journal><year>2007</year><book /><volume>17</volume><number>1</number><pages>152-155</pages><co_aut>et al.</co_aut></literature><literature><id>3001</id><title>Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms</title><author>Babovic-Vuksanovic D</author><journal>Mol Diagn Ther</journal><year>2007</year><book /><volume>11</volume><number>5</number><pages>303-311</pages><co_aut>OBrien JF</co_aut></literature><literature><id>2525</id><title>Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and I</title><author>Damen G</author><journal>J Pediatr Gastroenterol Nutr</journal><year>2004</year><book /><volume>38</volume><number>3</number><pages>282-287</pages><co_aut>et al.</co_aut></literature><literature><id>1315</id><title>Komrower Lecture. Congenital disorders of glycosylation (CDG): its all in it!</title><author>Jaeken J</author><journal>J Inherit Metab Dis</journal><year>2003</year><book /><volume>26</volume><number>0</number><pages>99-118</pages><co_aut /></literature><literature><id>1284</id><title>Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia</title><author>Briones P</author><journal>J Inherit Metab Dis</journal><year>2002</year><book /><volume>25</volume><number>8</number><pages>635-646</pages><co_aut>et al.</co_aut></literature><literature><id>1288</id><title>DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG)</title><author>Schollen E</author><journal>Eur J Hum Genet</journal><year>2002</year><book /><volume>10</volume><number>10</number><pages>643-648</pages><co_aut>et al.</co_aut></literature><literature><id>1181</id><title>Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype</title><author>Kjaergaard S</author><journal>Arch Dis Child</journal><year>2001</year><book /><volume>85</volume><number>0</number><pages>236-239</pages><co_aut>Schwartz M, Skovby F</co_aut></literature><literature><id>1283</id><title>A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases</title><author>de Lonlay P</author><journal>J Med Genet</journal><year>2001</year><book /><volume>38</volume><number>1</number><pages>14-19</pages><co_aut>et al.</co_aut></literature><literature><id>1297</id><title>Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications</title><author>van Geet C</author><journal>J Inherit Metab Dis</journal><year>2001</year><book /><volume>24</volume><number>4</number><pages>477-492</pages><co_aut>et al.</co_aut></literature><literature><id>1117</id><title>Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. Fi</title><author>Aebi M</author><journal>Glycoconj J</journal><year>1999</year><book /><volume>16</volume><number>0</number><pages>669-671</pages><co_aut>et al.</co_aut></literature><literature><id>950</id><title>The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoproterin syndrome type I)</title><author>Kristiansson B</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>112-124</pages><co_aut>et al.</co_aut></literature><literature><id>996</id><title>Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc: Man9G1cNAc2-PP-dolichyl glucosyltransferase&lt;/</title><author>Korner C</author><journal>Proc Natl Acad Sci USA</journal><year>1998</year><book /><volume>95</volume><number>22</number><pages>13200-205</pages><co_aut>et al.</co_aut></literature><literature><id>997</id><title>Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type IA</title><author>Matthijs G</author><journal>Am J Hum Genet</journal><year>1998</year><book /><volume>62</volume><number>0</number><pages>542-550</pages><co_aut>et al.</co_aut></literature><literature><id>1130</id><title>Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A</title><author>Kjaergaard S</author><journal>Acta Paediatr</journal><year>1998</year><book /><volume>87</volume><number>0</number><pages>884-888</pages><co_aut>et al.</co_aut></literature><literature><id>1005</id><title>Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I</title><author>Mayatepek E</author><journal>Acta Paediatr</journal><year>1997</year><book /><volume>86</volume><number>0</number><pages>1138-1140</pages><co_aut>et al.</co_aut></literature><literature><id>528</id><title>Mannose corrects altered N-glycolisation in carbohydrate-deficient glycoprotein syndrome fibroblasts</title><author>Panneerselvam K</author><journal>J Clin Invest</journal><year>1996</year><book /><volume>97</volume><number>6</number><pages>1478-1487</pages><co_aut>Freeze HH</co_aut></literature><literature><id>586</id><title>Congenital nephrotic syndrome: a novel phenotype of type I carbohydrate-deficent  glycoprotein syndrome</title><author>van der Knaap MS</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>787-791</pages><co_aut>et al.</co_aut></literature><literature><id>588</id><title>Hyperglycinaemia in child with carbohydrate-deficient glycoprotein syndrome type I</title><author>Subhedar NV</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>796-797</pages><co_aut>Isherwood DM, Davidson DC</co_aut></literature><literature><id>97</id><title>Disorders of glycoprotein degradation and structure: alpha-mannosidosis, beta-mannosidosis, fucosidosis, sialidosis, aspartylglucosminuria and carbohydrate- deficient glycoprotein syndrome</title><author>Thomas GH</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2529-2561</pages><co_aut>Beaudet AL</co_aut></literature><literature><id>225</id><title>Carbohydrate deficient glycoprotein syndrome: multiple abnormalities and diagnostic delay</title><author>Hutchesson AC</author><journal>Arch Dis Child</journal><year>1995</year><book /><volume>72</volume><number>0</number><pages>445-446</pages><co_aut>Gray RGF, Spencer DA, Keir G</co_aut></literature><literature><id>436</id><title>Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence</title><author>de Zegher F</author><journal>Pediatr Res</journal><year>1995</year><book /><volume>37</volume><number>0</number><pages>395-401</pages><co_aut>Jaeken J</co_aut></literature><literature><id>437</id><title>Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I</title><author>van Schaftingen E</author><journal>FEBS Lett</journal><year>1995</year><book /><volume>377</volume><number>0</number><pages>318-320</pages><co_aut>Jaeken J</co_aut></literature><literature><id>442</id><title>Carbohydrate-deficient glycoprotein syndrome - a fourth subtype</title><author>Stibler H</author><journal>Neuropediatrics</journal><year>1995</year><book /><volume>26</volume><number>5</number><pages>235-237</pages><co_aut>Stephani U, Kutsch U</co_aut></literature><literature><id>526</id><title>Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome</title><author>Akaboshi S</author><journal>Neuroradiology</journal><year>1995</year><book /><volume>37</volume><number>6</number><pages>491-495</pages><co_aut>Ohno K, Takeshita K</co_aut></literature><literature><id>527</id><title>Thrombophilia in a child with CDG-syndrome type I (Letter)</title><author>Funk M</author><journal>Thromb Haemost</journal><year>1995</year><book /><volume>74</volume><number>4</number><pages>1199-1200</pages><co_aut>et al.</co_aut></literature><literature><id>213</id><title>Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II</title><author>Jaeken J</author><journal>Arch Dis Child</journal><year>1994</year><book /><volume>71</volume><number>0</number><pages>123-127</pages><co_aut>et al.</co_aut></literature><literature><id>214</id><title>Carbohydrate deficient glycoprotein syndrome type I: ophthalmic aspects in four sicilian patients</title><author>Fiumara A</author><journal>Br J Ophthalmol</journal><year>1994</year><book /><volume>78</volume><number>11</number><pages>845-846</pages><co_aut>et al.</co_aut></literature><literature><id>215</id><title>Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease</title><author>Stibler H</author><journal>J Neurol Neurosurg Psychiatry</journal><year>1994</year><book /><volume>57</volume><number>5</number><pages>552-556</pages><co_aut>et al.</co_aut></literature><literature><id>35</id><title>The carbohydrate-deficient glycoprotein syndromes: an overview</title><author>Jaeken J</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>813-820</pages><co_aut>Carchon H</co_aut></literature><literature><id>216</id><title>Carbohydrate-deficient glycoprotein syndrome: peculiar group of new disorders</title><author>Hagberg BA</author><journal>Pediatr Neurol</journal><year>1993</year><book /><volume>9</volume><number>4</number><pages>255-262</pages><co_aut>et al.</co_aut></literature><literature><id>217</id><title>Carbohydrate-deficient glycoprotein (CDG) syndrome - a new variant, type III</title><author>Stibler H</author><journal>Neuropediatrics</journal><year>1993</year><book /><volume>24</volume><number>1</number><pages>51-52</pages><co_aut>Westerberg B, Hanefeld F, Hagberg B</co_aut></literature><literature><id>438</id><title>Early manifestations of the carbohydrate-deficient glycoprotein syndrome</title><author>Petersen MB</author><journal>J Pediatr</journal><year>1993</year><book /><volume>122</volume><number>0</number><pages>66-70</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>